Home Cart 0 Sign in  

[ CAS No. 905710-66-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 905710-66-9
Chemical Structure| 905710-66-9
Structure of 905710-66-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 905710-66-9 ]

Related Doc. of [ 905710-66-9 ]

Alternatived Products of [ 905710-66-9 ]

Product Details of [ 905710-66-9 ]

CAS No. :905710-66-9 MDL No. :MFCD11858305
Formula : C8H6BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :MKEWOMLQLUYQPK-UHFFFAOYSA-N
M.W : 212.04 Pubchem ID :53407897
Synonyms :

Calculated chemistry of [ 905710-66-9 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 44.98
TPSA : 44.02 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.71 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.69
Log Po/w (XLOGP3) : 1.24
Log Po/w (WLOGP) : 1.66
Log Po/w (MLOGP) : 1.59
Log Po/w (SILICOS-IT) : 2.32
Consensus Log Po/w : 1.7

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.27
Solubility : 1.13 mg/ml ; 0.00533 mol/l
Class : Soluble
Log S (Ali) : -1.76
Solubility : 3.66 mg/ml ; 0.0173 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.17
Solubility : 0.143 mg/ml ; 0.000673 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.7

Safety of [ 905710-66-9 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P261-P280-P305+P351+P338-P311 UN#:3439
Hazard Statements:H302+H312-H315-H319-H331-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 905710-66-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 905710-66-9 ]
  • Downstream synthetic route of [ 905710-66-9 ]

[ 905710-66-9 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 41963-20-6 ]
  • [ 905710-66-9 ]
YieldReaction ConditionsOperation in experiment
44%
Stage #1: With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane for 3 h; Heating / reflux
Stage #2: With sodium acetate In N,N-dimethyl-formamide at 80℃;
To a solution of 17 (10.0 g, 49.5 mmol) in carbon tetrachloride (200 mL) were added N-bromosuccinimide (8.81 g, 49.5 mmol) and 2,2'-azobis(isobutyronitrile) (414 mg, 5 mol percent), and the mixture was refluxed for 3 h. Water was added, and the mixture was extracted with chloroform. The organic layer was washed with brine and dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure. To the residue were added dimethylformamide (150 mL) and sodium acetate (20.5 g, 250 mmol), and the mixture was stirred at 80° C. overnight. Water was added, and the mixture was extracted with ether. The organic layer was washed with water and brine, and dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure. To the residue was added methanol (150 mL) and 1 mol/L sodium hydroxide (50 mL), and the mixture was stirred at room temperature for 1 h. The reaction mixture was concentrated to about a third of volume under reduced pressure. Water and hydrochloric acid were added, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and brine, and dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure, and the residue was purified by silica gel column chromatography (3:1 hexane/ethyl acetate) followed by trituration with dichloromethane to give 2-bromo-5-cyanobenzyl alcohol (4.63 g, overall 44percent): 1H NMR (300 MHz, DMSO-d6) δ (ppm) 4.51 (d, J=5.9 hz, 2H), 5.67 (t, J=5.6 Hz, 1H), 7.67 (dd, J=8.2, 2.0 Hz, 1H), 7.80 (s, J=8.2 Hz, 1H), 7.83 (d, J=2.0 Hz, 1H).
Reference: [1] Patent: US2007/265226, 2007, A1, . Location in patent: Page/Page column 58-59
[2] Journal of Medicinal Chemistry, 2006, vol. 49, # 15, p. 4447 - 4450
[3] Tetrahedron, 2011, vol. 67, # 52, p. 10082 - 10088
[4] Patent: WO2017/151489, 2017, A1,
[5] Patent: WO2018/156554, 2018, A1,
[6] Patent: US2007/286822, 2007, A1,
  • 2
  • [ 89003-95-2 ]
  • [ 905710-66-9 ]
YieldReaction ConditionsOperation in experiment
90% at 0℃; for 0.5 h; To a solution of 4-bromo-3-formylbenzonitrile (1 g, 0.0047 mol) in methanol (10 mL) was added sodium borohydride(NaBH4; 0.18 g, 0.0047 mol) in portions, and the resulting mixture was stirred at 0 °C for 30 minutes (min). The reaction was quenched with saturated ammonium chloride (NH4C1) solution, and the mixture was concentrated under vacuum to remove the methanol. The resulting mass was dissolved in EtOAc, and the organic layer was washed with 0 and brine, dried over Na2S04 and concentrated. Trituration of the colorless solid which was obtained with n-hexane provided the title compound as white solid (0.9 g, 90percent): mp: 131-133° C; NMR (400 MHz, CDCb) δ 7.86 (dt, J = 1.8, 0.9 Hz, 1H), 7.67 (d, / = 8.1 Hz, 1H), 7.45 (ddt, / = 8.2, 2.0, 0.7 Hz, 1H), 4.79 (s, 2H).
Reference: [1] Patent: WO2018/156554, 2018, A1, . Location in patent: Page/Page column 25
  • 3
  • [ 254744-14-4 ]
  • [ 905710-66-9 ]
YieldReaction ConditionsOperation in experiment
1.51 g With water; sodium hydroxide In methanol for 4 h; Using a modification of the procedure by Baker and co-workers,refPreviewPlaceHolder12 1,1'-azobis(cyclohexanecarbonitrile) (0.343 g, 1.41 mmol) was added to a solution of 4-bromo-3-methylbenzonitrile (2.75 g, 14.1 mmol) and N-bromosuccinimide (2.75 g, 15.5 mmol) in α,α,α-trifluorotoluene (70 mL). The mixture was heated to reflux for 18 h. Upon cooling to room temperature, H2O (75 mL) was added and the mixture extracted with CH2Cl2 (3.x.50 mL). The combined organic phases were dried (MgSO4) and concentrated in vacuo. NaOAc (5.76 g, 70.0 mmol) was added to a solution of the residue in dimethyl formamide (45 mL) and the mixture was heated to 90 °C for 18 h. Upon cooling to room temperature, H2O (100 mL) was added and the mixture was extracted with EtOAc (3.x.75 mL). The combined organic phases were washed with brine (75 mL), dried (MgSO4) and concentrated in vacuo. Aqueous NaOH (2 M, 7.1 mL, 14.2 mmol) was added to a solution of the residue in MeOH (60 mL) and the mixture was stirred for 4 h. The solution was concentrated to 1/4 of its volume in vacuo and the mixture was extracted with EtOAc (3.x.50 mL). The combined organic phases were washed with brine (50 mL), dried (MgSO4) and concentrated in vacuo. The product was purified by column chromatography (20percent EtOAc/petroleum ether) to give the alcohol 27 (1.51 g, 51percent) as needles (hexane); mp=152-154 °C (hexane); δH (400 MHz, DMSO-d6): 7.83-7.86 (1H, m, ArH); 7.81 (1H, d, J 8.2 Hz, ArH), 7.68 (1H, dd, J 8.2, 2.1 Hz, ArH), 5.69 (1H, t, J 5.6 Hz, OH), 4.53 (2H, d, J 5.6 Hz, CH2); δC (101 MHz, DMSO-d6): 143.1, 133.4, 131.9, 131.0, 126.6, 118.3, 110.6, 62.1. The data were consistent with those reported by Baker and co-workers.refPreviewPlaceHolder12 S.J. Baker, Y.-K. Zhang, T. Akama, A. Lau, H. Zhou, V. Hernandez, W. Mao, M.R.K. Alley, V. Sanders and J.J. Plattner. J. Med. Chem., 49 (2006), pp. 4447-4450. Article | PDF (271 K) | View Record in Scopus| Cited By in Scopus (14)
14 g With water; sodium hydroxide In methanol at 20℃; for 2 h; j0402j A mixture of 2-bromo-5-cyanobenzyl acetate (crude product, 13.5 g, 54.6 mmol, 1.0 eq), NaOH (2.55 g, 63.9 mmol, 1.2 eq) in methanol (150 ml) and water (50 mL) was stirred at room temperature for 2h. The water (150 ml) was added to mixture. Then the mixture was extracted with EA (3 x 6OmL) and the organic phase was washed by brine, dried with Na2SO4, concentrated in vacuum to give 4-bromo-3-(hydroxymethyl)benzonitrile (14.0 g) as brown solid.
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 15, p. 4447 - 4450
[2] Tetrahedron, 2011, vol. 67, # 52, p. 10082 - 10088
[3] Patent: WO2017/151489, 2017, A1, . Location in patent: Paragraph 0402
[4] Patent: US2007/286822, 2007, A1, . Location in patent: Page/Page column 48; 60
  • 4
  • [ 190197-86-5 ]
  • [ 905710-66-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 15, p. 4447 - 4450
[2] Tetrahedron, 2011, vol. 67, # 52, p. 10082 - 10088
[3] Patent: WO2017/151489, 2017, A1,
[4] Patent: US2007/286822, 2007, A1,
  • 5
  • [ 845616-12-8 ]
  • [ 905710-66-9 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 11, p. 3310 - 3313
  • 6
  • [ 160313-49-5 ]
  • [ 905710-66-9 ]
Reference: [1] Patent: WO2018/156554, 2018, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 905710-66-9 ]

Aryls

Chemical Structure| 90110-98-8

[ 90110-98-8 ]

3-Bromo-4-(hydroxymethyl)benzonitrile

Similarity: 0.98

Chemical Structure| 1261609-83-9

[ 1261609-83-9 ]

2-Bromo-5-(hydroxymethyl)benzonitrile

Similarity: 0.95

Chemical Structure| 1086429-88-0

[ 1086429-88-0 ]

2-Bromo-3-(hydroxymethyl)benzonitrile

Similarity: 0.93

Chemical Structure| 52780-15-1

[ 52780-15-1 ]

3-Bromo-2-methylbenzonitrile

Similarity: 0.84

Chemical Structure| 22433-89-2

[ 22433-89-2 ]

4-Bromoisophthalonitrile

Similarity: 0.82

Bromides

Chemical Structure| 90110-98-8

[ 90110-98-8 ]

3-Bromo-4-(hydroxymethyl)benzonitrile

Similarity: 0.98

Chemical Structure| 1261609-83-9

[ 1261609-83-9 ]

2-Bromo-5-(hydroxymethyl)benzonitrile

Similarity: 0.95

Chemical Structure| 1086429-88-0

[ 1086429-88-0 ]

2-Bromo-3-(hydroxymethyl)benzonitrile

Similarity: 0.93

Chemical Structure| 52780-15-1

[ 52780-15-1 ]

3-Bromo-2-methylbenzonitrile

Similarity: 0.84

Chemical Structure| 22433-89-2

[ 22433-89-2 ]

4-Bromoisophthalonitrile

Similarity: 0.82

Alcohols

Chemical Structure| 90110-98-8

[ 90110-98-8 ]

3-Bromo-4-(hydroxymethyl)benzonitrile

Similarity: 0.98

Chemical Structure| 1261609-83-9

[ 1261609-83-9 ]

2-Bromo-5-(hydroxymethyl)benzonitrile

Similarity: 0.95

Chemical Structure| 1086429-88-0

[ 1086429-88-0 ]

2-Bromo-3-(hydroxymethyl)benzonitrile

Similarity: 0.93

Chemical Structure| 147034-01-3

[ 147034-01-3 ]

(2,5-Dibromophenyl)methanol

Similarity: 0.81

Chemical Structure| 149104-89-2

[ 149104-89-2 ]

(4-Bromo-3-methylphenyl)methanol

Similarity: 0.79

Nitriles

Chemical Structure| 90110-98-8

[ 90110-98-8 ]

3-Bromo-4-(hydroxymethyl)benzonitrile

Similarity: 0.98

Chemical Structure| 1261609-83-9

[ 1261609-83-9 ]

2-Bromo-5-(hydroxymethyl)benzonitrile

Similarity: 0.95

Chemical Structure| 1086429-88-0

[ 1086429-88-0 ]

2-Bromo-3-(hydroxymethyl)benzonitrile

Similarity: 0.93

Chemical Structure| 52780-15-1

[ 52780-15-1 ]

3-Bromo-2-methylbenzonitrile

Similarity: 0.84

Chemical Structure| 22433-89-2

[ 22433-89-2 ]

4-Bromoisophthalonitrile

Similarity: 0.82